This is a preview of subscription content, log in via an institution to check access.
Reference
Chijimatsu I, et al. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation. Pediatric Blood and Cancer 64: e26697, No. 12, Dec 2017. Available from: URL: http://doi.org/10.1002/pbc.26697 - Japan
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1678, 20 (2017). https://doi.org/10.1007/s40278-017-38566-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-38566-y